Invasive brain mapping identifies personalized therapeutic neuromodulation targets that suppress OCD network activity.
Saved in:
| Title: | Invasive brain mapping identifies personalized therapeutic neuromodulation targets that suppress OCD network activity. |
|---|---|
| Authors: | Moses Lee A; Weill Institute for Neurosciences, University of California, San Francisco, US. andrewmoses.lee@ucsf.edu.; Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, US. andrewmoses.lee@ucsf.edu., Kist A; Weill Institute for Neurosciences, University of California, San Francisco, US.; Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, US., Alvarez J; Weill Institute for Neurosciences, University of California, San Francisco, US.; Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, US., Sellers KK; Weill Institute for Neurosciences, University of California, San Francisco, US.; Department of Neurological Surgery, University of California, San Francisco, US., Khambhati AN; Weill Institute for Neurosciences, University of California, San Francisco, US.; Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, US.; Department of Neurological Surgery, University of California, San Francisco, US., Sugrue LP; Weill Institute for Neurosciences, University of California, San Francisco, US.; Department of Radiology and Biomedical Imaging, University of California, San Francisco, US., Reid LB; Weill Institute for Neurosciences, University of California, San Francisco, US.; Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, US.; Department of Radiology and Biomedical Imaging, University of California, San Francisco, US., Kadlec K; Weill Institute for Neurosciences, University of California, San Francisco, US.; Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, US., Ray S; Weill Institute for Neurosciences, University of California, San Francisco, US.; Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, US., Fan JM; Weill Institute for Neurosciences, University of California, San Francisco, US.; Department of Neurology, University of California, San Francisco, US., Allawala AB; Weill Institute for Neurosciences, University of California, San Francisco, US.; Department of Neurological Surgery, University of California, San Francisco, US., Racine CA; Weill Institute for Neurosciences, University of California, San Francisco, US.; Department of Neurological Surgery, University of California, San Francisco, US., Norbu T; Weill Institute for Neurosciences, University of California, San Francisco, US.; Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, US., Astudillo D; Weill Institute for Neurosciences, University of California, San Francisco, US.; Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, US., Tremblay-McGaw AG; Weill Institute for Neurosciences, University of California, San Francisco, US.; Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, US., Becker N; Weill Institute for Neurosciences, University of California, San Francisco, US.; Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, US., Verhein J; Weill Institute for Neurosciences, University of California, San Francisco, US.; Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, US., Alhourani A; Department of Neurological Surgery, University of California, San Francisco, US., Starr PA; Weill Institute for Neurosciences, University of California, San Francisco, US.; Department of Neurological Surgery, University of California, San Francisco, US., Chang EF; Weill Institute for Neurosciences, University of California, San Francisco, US.; Department of Neurological Surgery, University of California, San Francisco, US., Krystal AD; Weill Institute for Neurosciences, University of California, San Francisco, US.; Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, US. |
| Source: | Translational psychiatry [Transl Psychiatry] 2025 Oct 31; Vol. 15 (1), pp. 448. Date of Electronic Publication: 2025 Oct 31. |
| Publication Type: | Journal Article; Case Reports |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101562664 Publication Model: Electronic Cited Medium: Internet ISSN: 2158-3188 (Electronic) Linking ISSN: 21583188 NLM ISO Abbreviation: Transl Psychiatry Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
